116 3rd St SE
Cedar Rapids, Iowa 52401
U.S. FDA approves first generic version of Mylan’s EpiPen
The U.S. Food and Drug Administration on Thursday approved Teva Pharmaceutical Industries Ltd's generic version of Mylan NV's EpiPen for the emergency treatment of allergic reactions.
'Today's approval of the first generic version of the most-widely prescribed epinephrine auto-injector in the U.S. is part of our long-standing commitment to advance access to lower cost, safe and effective generic alternatives once patents and other exclusivities no longer prevent approval,” FDA Commissioner Scott Gottlieb said.
EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016. REUTERS/Jim Bourg/File Photo
Daily Newsletters